| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.01 |
| mRNA | Nilotinib | GDSC1000 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.09 | 0.01 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.076 | 0.01 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.4 | 0.02 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.02 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |